Marc Pelletier, PhD, Biopharmaceutical Process Specialist featured in Pharma Almanac's

Marc Pelletier, PhD, Biopharmaceutical Process Specialist featured in Pharma Almanac's
Posted: Mar 12 2018
Marc Pelletier, PhD, Biopharmaceutical Process Specialist at CRB, is featured in Pharma Almanac's current issue, entitled "Death to Cleanrooms in Biopharmaceutical Manufacturing." 


For as long as most of us can remember, the manufacture and purification of biologic drug substances has mostly been performed in cleanrooms. Recently, advances in the design, form, function and operation of  bioprocessing equipment has made it possible to close—or functionally close—biological active ingredient (API) manufacturing operations. As expressed in the most recent regulatory guidelines (PIC/S 2017, Annex II), closed bioprocessing can be moved into simpler, unclassified environments and even outdoors! Learn why this strong endorsement of closed processing provides enormous opportunity and cost benefits to drug manufacturers here. https://www.pharmasalmanac.com/articles/death-to-cleanrooms-in-biopharmaceutical-manufacturing

 

Death to Cleanrooms CRBnet

Search News